Recruiting
A Study of a Decision Tool for People Considering Breast Reconstruction Surgery
The purpose of this study is to find out whether it is practical (feasible) to do a larger study looking at the effectiveness of the Breast Reconstruction Decision Aid Tool (RECONJOINT) for breast reconstruction surgery.
ClinicalTrials.gov IDNCT07335354
PhaseNA
Enrollment131
SponsorMemorial Sloan Kettering Cancer Center
Age18 Years
SexALL
Conditions studied
Breast Cancer
About this study
The purpose of this study is to find out whether it is practical (feasible) to do a larger study looking at the effectiveness of the Breast Reconstruction Decision Aid Tool (RECONJOINT) for breast reconstruction surgery.
Interventions
- Other: RECONJOINT — RECONJOINT is a Breast Reconstruction Decision Aid
Primary outcomes
- Feasibility determined by participant accrual (<60 days after initial reconstructive surgery consult and before pt's breast reconstruction surgery)
Eligibility information
Participant Inclusion Criteria
Focus Group Participants
* A diagnosed genetic predisposition to breast cancer or a diagnosis of ductal carcinoma in situ or any invasive cancer confirmed through review of the medical record
* ≥18 years old
* Considering post-mastectomy breast reconstruction
RCT Participants (Patients)
* A diagnosed genetic predisposition to breast cancer or a diagnosis of ductal carcinoma in situ or any invasive cancer confirmed through review of the medical record
* ≥18 years old
* Considering post-mastectomy breast reconstruction
* Have an appointment scheduled for consultation with a plastic surgery provider
RCT Participants (Physicians)
* Provides breast reconstruction care ≥ 50% of the time. This is defined as over half of the surgeon's cases in the preceding calendar year being related to breast reconstruction surgery.
Participant Exclusion Criteria
Focus Group Participants
* Not considering post-mastectomy breast reconstruction
* Non-English proficiency
RCT Participants (Patients)
* Not considering postmastectomy breast reconstruction
* Recurrent or metastatic breast cancer
* Male sex
* Non-English proficiency
RCT Participants (Physicians)
* Does not provide breast reconstruction care at least 50% of the time
* Non-English proficiency
Study locations
- Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey 07920 United States
- Memorial Sloan Kettering Monmouth, Middletown, New Jersey 07748 United States
- Memorial Sloan Kettering Bergen, Montvale, New Jersey 07645 United States
- Memorial Sloan Kettering Commack, Commack, New York 11725 United States
- Memorial Sloan Kettering Westchester, Harrison, New York 10604 United States
- Memorial Sloan Kettering Cancer Center, New York, New York 10065 United States
- Memorial Sloan Kettering Nassau, Rockville Centre, New York 11553 United States
- Duke Cancer Institute (Data collection only), Durham, North Carolina 27710 United States
- Duke Cancer Institute (Data collection only), Durham, North Carolina 27710 United States
Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.